MYCN and neoplasm: We found that indisulam treatment promoted a remarkable infiltration of NK cells in the c-MYC tumors implanted in Rag2-/- mice, and various immune cells, including T and NK cells in the transgenic TH-MYCN/ALKF1178L tumors, suggesting that indisulam induced an “inflamed” tumor microenvironment.